101 related articles for article (PubMed ID: 3163939)
1. Modulation of 6-thioguanine activity by guanine in human promyelocytic leukemia HL-60 cells.
Cheng HW; Armstrong RD; Sadée W
Cancer Res; 1988 Jul; 48(13):3648-51. PubMed ID: 3163939
[TBL] [Abstract][Full Text] [Related]
2. Cell cycle events associated with the termination of proliferation by cytotoxic and differentiation-inducing actions of 6-thioguanine on HL-60 cells.
Schwartz EL; Blair OC; Sartorelli AC
Cancer Res; 1984 Sep; 44(9):3907-10. PubMed ID: 6589046
[TBL] [Abstract][Full Text] [Related]
3. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
Zimm S; Johnson GE; Poplack DG
Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
[TBL] [Abstract][Full Text] [Related]
5. Altered 5-phosphoribosyl 1-pyrophosphate amidotransferase activity in 6-thioguanine-resistant HL-60 human acute promyelocytic leukemia cells.
Ishiguro K; Sartorelli AC
Cancer Res; 1984 Sep; 44(9):3679-85. PubMed ID: 6589043
[TBL] [Abstract][Full Text] [Related]
6. Purine metabolism in myeloid precursor cells during maturation. Studies with the HL-60 cell line.
Lucas DL; Webster HK; Wright DG
J Clin Invest; 1983 Dec; 72(6):1889-900. PubMed ID: 6139386
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of 6-thioguanine and alpha-interferon as a therapeutic combination in HL-60 and natural killer cells.
Tan YY; Epstein LB; Armstrong RD
Cancer Res; 1989 Aug; 49(16):4431-4. PubMed ID: 2743331
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a relationship between intracellular GTP levels and the induction of HL-60 leukemia cell differentiation by 5,10-dideazatetrahydrofolic acid (DDATHF).
Sokoloski JA; Pizzorno G; Beardsley GP; Sartorelli AC
Oncol Res; 1993; 5(8):293-9. PubMed ID: 8012061
[TBL] [Abstract][Full Text] [Related]
9. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
Frank DA; Sartorelli AC
Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.
Ishiguro K; Schwartz EL; Sartorelli AC
J Cell Physiol; 1984 Nov; 121(2):383-90. PubMed ID: 6593322
[TBL] [Abstract][Full Text] [Related]
11. A decrease in the intracellular guanosine 5'-triphosphate concentration is necessary for granulocytic differentiation of HL-60 cells, but growth cessation and differentiation are not associated with a change in the activation state of Ras, the transforming principle of HL-60 cells.
Pilz RB; Huvar I; Scheele JS; Van den Berghe G; Boss GR
Cell Growth Differ; 1997 Jan; 8(1):53-9. PubMed ID: 8993834
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of c-myc expression in human promyelocytic leukemia and colon adenocarcinoma cells by 6-thioguanine.
Schwartz EL; Chamberlin H; Brechbühl AB
Biochem Pharmacol; 1990 Dec; 40(11):2449-55. PubMed ID: 1702632
[TBL] [Abstract][Full Text] [Related]
13. [Differential cell growth inhibition and terminal differentiation induction by chemotherapeutic agents of a human acute myelogenous leukemia cell line (HL-60) in vitro].
Himori T; Ohnuma T; Wakui A
Gan To Kagaku Ryoho; 1984 Aug; 11(8):1605-11. PubMed ID: 6591856
[TBL] [Abstract][Full Text] [Related]
14. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of the differentiation-inducing properties of 6-thioguanine by hypoxanthine and its nucleosides in HL-60 promyelocytic leukemia cells.
Ishiguro K; Sartorelli AC
Cancer Res; 1985 Jan; 45(1):91-5. PubMed ID: 3855287
[TBL] [Abstract][Full Text] [Related]
16. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.
Yamane K; Schupp JE; Kinsella TJ
Cancer Res; 2007 Jul; 67(13):6286-92. PubMed ID: 17616687
[TBL] [Abstract][Full Text] [Related]
17. Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.
Dervieux T; Blanco JG; Krynetski EY; Vanin EF; Roussel MF; Relling MV
Cancer Res; 2001 Aug; 61(15):5810-6. PubMed ID: 11479220
[TBL] [Abstract][Full Text] [Related]
18. Imbalance in the nucleotide pools of myeloid leukemia cells and HL-60 cells: correlation with cell-cycle phase, proliferation, differentiation, and transformation.
de Korte D; Haverkort WA; de Boer M; van Gennip AH; Roos D
Cancer Res; 1987 Apr; 47(7):1841-7. PubMed ID: 3469022
[TBL] [Abstract][Full Text] [Related]
19. Methylation of mercaptopurine, thioguanine, and their nucleotide metabolites by heterologously expressed human thiopurine S-methyltransferase.
Krynetski EY; Krynetskaia NF; Yanishevski Y; Evans WE
Mol Pharmacol; 1995 Jun; 47(6):1141-7. PubMed ID: 7603453
[TBL] [Abstract][Full Text] [Related]
20. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
Grant S; Bhalla K; Rauscher F; Cadman E
Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
